Sakai, Masafumi
Mutsuzaki, Hirotaka
Shimizu, Yukiyo
Okamoto, Yoshikazu
Nakajima, Takahito
Article History
Received: 7 April 2022
Accepted: 13 July 2022
First Online: 23 July 2022
Declarations
:
: This study was approved and conducted by the Ethics Committee of Ibaraki Prefectural University of Health Sciences. The approval number is 'e251'. The main purpose of the study was explained verbally to all subjects and their written informed consent was obtained after they agreed that the data obtained would be revealed to them.
: Subjects who participated in the study were verbally informed that their clinical and imaging data would be disclosed anonymously. Written informed consent was then obtained from all participants.
: The authors declare that they have no competing interests.